EuPatch (European Paediatric Amblyopia Treatment Study for Children): The role of glasses wearing in amblyopia treatment

Mise à jour : Il y a 4 ans
Référence : ISRCTN51712593

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

Background and study aims Amblyopia (also called lazy eye) is the most common disease affecting vision in childhood. Currently 30% of children treated for amblyopia do not reach normal vision after a year or more of treatment. Amblyopia is usually treated with glasses wearing and by patching the better eye (wearing an eye patch). There is controversy whether a long period of glasses wearing before patching, called refractive adaptation, helps in treating children with amblyopia. The purpose of this study is to perform a trial to test whether refractive adaptation before patching improves the number of successfully treated children with amblyopia. Who can participate? Amblyopic children between 3 and 8 years of age. What does the study involve? Participants will be randomly allocated to two groups. Half of the participants will wear glasses for 18 weeks before patching for amblyopia is started, whereas the other half will wear the glasses for 3 weeks before patching. What are the possible benefits and risks of participating? The participants will receive information material for parents, teachers and children about amblyopia. Decorated patches will be given to children. Waiting time for appointments is likely to be shorter. It could be that the total treatment time is reduced. Possible occurrence of side effects will be very similar to the usual clinical treatment and could be rarely increase of squint, double vision or reduced vision in the better eye (which is almost always reversible). Where is the study run from? University of Leicester, Moorfields Eye Hospital, University of Graz, University of Heidelberg, Lead Centre: University of Leicester When is the study starting and how long is it expected to run for? The anticipated start date is June 2013 for a duration of 3 years; recruitment will be during the first 2.5 years of the study. Who is funding the study? Action Medical Research, UK Who is the main contact? Professor Irene Gottlob [email protected]


Critère d'inclusion

  • Amblyopia

Liens